KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 147 filers reported holding KARUNA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,421,863 | -29.5% | 61,635 | -9.5% | 0.01% | -29.4% |
| Q2 2023 | $14,776,376 | -20.9% | 68,141 | -33.7% | 0.02% | -19.0% |
| Q1 2023 | $18,678,586 | +167.3% | 102,833 | +189.2% | 0.02% | +162.5% |
| Q4 2022 | $6,987,344 | +271.7% | 35,559 | +115.6% | 0.01% | +300.0% |
| Q2 2021 | $1,880,000 | -5.2% | 16,491 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $1,983,000 | +6510.0% | 16,491 | +5490.2% | 0.00% | – |
| Q4 2020 | $30,000 | -99.9% | 295 | -100.0% | 0.00% | -100.0% |
| Q3 2020 | $51,945,000 | -48.2% | 671,829 | -25.3% | 0.06% | -52.6% |
| Q2 2020 | $100,228,000 | +124.3% | 899,227 | +44.9% | 0.14% | +84.9% |
| Q1 2020 | $44,677,000 | +108.5% | 620,512 | +118.2% | 0.07% | +143.3% |
| Q4 2019 | $21,426,000 | +141.5% | 284,400 | -47.7% | 0.03% | +130.8% |
| Q3 2019 | $8,873,000 | +159.4% | 543,698 | +218.2% | 0.01% | +160.0% |
| Q2 2019 | $3,421,000 | – | 170,881 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $142,043,933 | 58.49% |
| Nan Fung Group Holdings Ltd | 225,688 | $40,993,968 | 27.90% |
| Sofinnova Investments, Inc. | 1,773,124 | $322,070,243 | 20.60% |
| Artia Global Partners LP | 88,831 | $16,135,263 | 5.96% |
| DAFNA Capital Management LLC | 78,573 | $14,272,000 | 4.28% |
| First Light Asset Management, LLC | 243,675 | $44,261,127 | 3.98% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $3,966,473 | 2.74% |
| Sands Capital Ventures, LLC | 58,895 | $10,697,688 | 2.64% |
| ARCH Venture Management, LLC | 30,000 | $5,449,200 | 2.63% |
| Logos Global Management LP | 100,000 | $18,164,000 | 2.60% |